Inovio Pharmaceuticals
INO
#8897
Rank
HK$1.10 B
Marketcap
HK$16.11
Share price
2.48%
Change (1 day)
-48.49%
Change (1 year)

Earnings for Inovio Pharmaceuticals (INO)

Earnings in 2025 (TTM): -HK$0.85 Billion

According to Inovio Pharmaceuticals's latest financial reports the company's current earnings are HK$0.18 Million. In 2024 the company made an earning of -HK$0.84 Billion, an increase over its 2023 earnings that were of -HK$1.05 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Inovio Pharmaceuticals from 1999 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -HK$0.85 Billion1.06%
2024 -HK$0.84 Billion-20.03%
2023 -HK$1.05 Billion-51.56%
2022 -HK$2.16 Billion-8.26%
2021 -HK$2.35 Billion95.4%
2020 -HK$1.21 Billion36.62%
2019 -HK$0.88 Billion20.19%
2018 -HK$0.74 Billion10.94%
2017 -HK$0.66 Billion9.59%
2016 -HK$0.61 Billion118.9%
2015 -HK$0.28 Billion-10.67%
2014 -HK$0.31 Billion83.32%
2013 -HK$0.17 Billion
2011 -HK$0.18 Billion15.64%
2010 -HK$0.15 Billion37.7%
2009 -HK$0.11 Billion2.19%
2008 -HK$0.11 Billion-14.09%
2007 -HK$0.13 Billion19.12%
2006 -HK$0.11 Billion9.62%
2005 -HK$94.78 Million5.77%
2004 -HK$89.61 Million73.08%
2003 -HK$51.78 Million12.75%
2002 -HK$45.92 Million
2000 -HK$69.5 Million53.93%
1999 -HK$45.16 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Pfizer
PFE
HK$92.26 B-11,064.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
HK$252.18 B-30,070.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Arrowhead Pharmaceuticals
ARWR
-HK$0.59 Billion-30.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$127.81 B-15,289.84%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Merck
MRK
HK$179.74 B-21,461.43%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
HK$72.57 B-8,724.97%๐Ÿ‡ฌ๐Ÿ‡ง UK
Gilead Sciences
GILD
HK$76.95 B-9,245.91%๐Ÿ‡บ๐Ÿ‡ธ USA
Cleveland BioLabs
CBLI
-HK$21.43 Million-97.45%๐Ÿ‡บ๐Ÿ‡ธ USA